Volume 1, Issue 3, Fall 2025

View Volume 1, Issue 3, Fall 2025

Interstitial Lung Disease in 2025: Updated Classification, Precision Diagnostics, and Expanding Therapeutic Frontiers
Updates in Allergic Bronchopulmonary Aspergillosis
Antifibrotics in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases
Management of Pulmonary Tuberculosis in 2025: An Update for the Respirologist

Published: 2025-12-16

Full Issue

Full Issue PDF (en)

Articles

Interstitial Lung Disease in 2025: Updated Classification, Precision Diagnostics, and Expanding Therapeutic Frontiers

Nathan Hambly, MD (Author)

4–10
- PDF (en)
Updates in Allergic Bronchopulmonary Aspergillosis

Shaonie Ton-Leclerc, MD, Anne Ellis, MD (Author)

12–16
- PDF (en)
Antifibrotics in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases

Yassmin Behzadian, MD, FRCPC, Ambrose Lau, MD, MEd, FRCPC (Author)

17–21
- PDF (en)
Management of Pulmonary Tuberculosis in 2025: An Update for the Respirologist

Natasha Sabur, MD, MPH, FRCPC (Author)

22–27
- PDF (en)